Mandate

Vinge has advised SmartCella Holding AB in connection with fund raising

July 08, 2024 M&A

Vinge has advised SmartCella Holding AB in connection with its fund raising of EUR 50 million. The capital was invested by, among others, AstraZeneca, the Fourth Swedish National Pension Fund, AMF Pension, SEB-Stiftelsen, Handelsbanken Fonder and RoosGruppen AB. SmartCella is a world-leading biotechnology company pioneering the future of targeted therapies by combining first-in-class delivery platforms with cutting-edge cell and gene therapies.

Related

Vinge has advised Stendörren Fastigheter in connection with a directed share issue of approximately SEK 300 million

Vinge has advised the property company Stendörren Fastigheter AB (publ) in connection with a directed share issue through which the company raises proceeds of approximately SEK 300 million before transaction costs.
May 14, 2025

Vinge has advised EQT AB in connection with its bond issue in the aggregate principal amount of USD 500,000,000

EQT AB (publ) has issued senior bonds in the aggregate principal amount of USD 500,000,000 with an interest rate of 5.850%, due 2035, at a price equal to 99.783% of the aggregate principal amount thereof.
May 13, 2025

Vinge has advised Qlik in connection with acquisition

Vinge has advised the Qlik Group in connection with its acquisition of the Qloud Cover Migration technology from Stretch Qonnect. This automated solution, to be branded as the Qlik Analytics Migration Tool, eliminates the complexity of migrating from QlikView, Qlik Sense, and NPrinting to Qlik Cloud – a persistent barrier to cloud adoption.
May 13, 2025